BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34427588)

  • 1. JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.
    McGraw JM; Thelen F; Hampton EN; Bruno NE; Young TS; Havran WL; Witherden DA
    J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34427588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation.
    Witherden DA; Verdino P; Rieder SE; Garijo O; Mills RE; Teyton L; Fischer WH; Wilson IA; Havran WL
    Science; 2010 Sep; 329(5996):1205-10. PubMed ID: 20813954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial immunotherapy induces tumor-infiltrating CD8
    Van Braeckel-Budimir N; Dolina JS; Wei J; Wang X; Chen SH; Santiago P; Tu G; Micci L; Al-Khami AA; Pfister S; Ram S; Sundar P; Thomas G; Long H; Yang W; Potluri S; Salek-Ardakani S
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAML immunotherapy targets recently activated tumor-infiltrating CD8
    Eschweiler S; Wang A; Ramírez-Suástegui C; von Witzleben A; Li Y; Chee SJ; Simon H; Mondal M; Ellis M; Thomas GJ; Chandra V; Ottensmeier CH; Vijayanand P
    Cell Rep; 2023 Feb; 42(2):112040. PubMed ID: 36701231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment.
    Cheng S; Li M; Li C; Dai Y; Zhuo J; Wang J; Qian J; Hao Z
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):382-396. PubMed ID: 38625487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral CD8
    Horton BL; Williams JB; Cabanov A; Spranger S; Gajewski TF
    Cancer Immunol Res; 2018 Jan; 6(1):14-24. PubMed ID: 29097422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The junctional adhesion molecule-like protein (JAML) is important for the inflammatory response during contact hypersensitivity.
    Mraz V; Lohmann RKD; Menzel M; Hawkes A; Vaher H; Funch AB; Jee MH; Gadsbøll AØ; Weber JF; Yeung K; Ødum N; Woetmann A; McKay D; Witherden D; Geisler C; Bonefeld CM
    Contact Dermatitis; 2023 Nov; 89(5):323-334. PubMed ID: 37619972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional Deletion of
    Raghavan S; Tovbis-Shifrin N; Kochel C; Sawant A; Mello M; Sathe M; Blumenschein W; Muise ES; Chackerian A; Pinheiro EM; Rosahl TW; Luche H; de Waal Malefyt R
    Front Immunol; 2021; 12():752348. PubMed ID: 34912335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic adenovirus decreases the proportion of TIM-3
    Liikanen I; Basnet S; Quixabeira DCA; Taipale K; Hemminki O; Oksanen M; Kankainen M; Juhila J; Kanerva A; Joensuu T; Tähtinen S; Hemminki A
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35193929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into γδ T cell costimulation by an anti-JAML antibody.
    Verdino P; Witherden DA; Ferguson MS; Corper AL; Schiefner A; Havran WL; Wilson IA
    Structure; 2011 Jan; 19(1):80-9. PubMed ID: 21220118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade.
    Singh S; Roszik J; Saini N; Singh VK; Bavisi K; Wang Z; Vien LT; Yang Z; Kundu S; Davis RE; Bover L; Diab A; Neelapu SS; Overwijk WW; Rai K; Singh M
    Front Immunol; 2022; 13():794684. PubMed ID: 35720386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR6 is required for antitumor efficacy of intratumoral CD8
    Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
    Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
    J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
    Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.